These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5582281)

  • 41. PRODUCTION OF MAMMARY TUMOURS WITH 3-METHYLCHOLANTHRENE.
    DANIEL PM; PRICHARD MM
    Nature; 1964 Feb; 201():578-80. PubMed ID: 14160642
    [No Abstract]   [Full Text] [Related]  

  • 42. Descriptive summary on breast tumors and leukemia induced in female Wister rats receiving gastric instillations of 3-methylcholanthrene.
    Shimkin MB; Acuff M; Thatcher D; Gruenstein M
    Natl Cancer Inst Monogr; 1966 Sep; 22():33-59. PubMed ID: 5923321
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of 3-methylcholanthrene on thyroid function in Sprague-Dawley rats.
    Newman WC; Moon RC
    Cancer Res; 1966 Sep; 26(9):1938-42. PubMed ID: 5924959
    [No Abstract]   [Full Text] [Related]  

  • 44. Influence of estrogens and endocrine ablation on duration of remission produced by ovariectomy or androgen treatment of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Teller MN; Kaufman RJ; Bowie M; Stock CC
    Cancer Res; 1969 Feb; 29(2):349-52. PubMed ID: 5765416
    [No Abstract]   [Full Text] [Related]  

  • 45. N-nitrosomethylurea as mammary gland carcinogen in rats.
    Gullino PM; Pettigrew HM; Grantham FH
    J Natl Cancer Inst; 1975 Feb; 54(2):401-14. PubMed ID: 1113323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Virus particles in rat mammary tumors of varying origin.
    Chopra H; Taylor DJ
    J Natl Cancer Inst; 1970 May; 44(5):1141-7. PubMed ID: 4328186
    [No Abstract]   [Full Text] [Related]  

  • 47. Combination therapy of 3-methylcholanthrene-induced mammary carcinoma in rats: effect of chemotherapy, ovariectomy, and food restriction.
    Gropper L; Shimkin MB
    Cancer Res; 1967 Jan; 27(1):26-32. PubMed ID: 6071371
    [No Abstract]   [Full Text] [Related]  

  • 48. Patterns of incorporation of thymidine in the female genital and other organs of mice, treated with 20-methylcholanthrene, estradiol and ovariectomy.
    Klavins JV; Wessely Z
    Oncology; 1973; 27(6):502-19. PubMed ID: 4742677
    [No Abstract]   [Full Text] [Related]  

  • 49. Ducto-alveolar growth in mammary glands of adrenogonadectomized male rats bearing mammotropic pituitary tumors.
    CLIFTON KH; FURTH J
    Endocrinology; 1960 Jun; 66():893-7. PubMed ID: 13810707
    [No Abstract]   [Full Text] [Related]  

  • 50. [Morphological changes in transplanted cancer of the mammary gland in rats after hormone therapy].
    LAGOVA ND; KONOPLEV VP
    Arkh Patol; 1962; 24(10)():38-44. PubMed ID: 13928074
    [No Abstract]   [Full Text] [Related]  

  • 51. Chemical carcinogen-induced alveolar nodules in organ culture of mouse mammary gland.
    Banerjee MR; Wood BG; Washburn LL
    J Natl Cancer Inst; 1974 Nov; 53(5):1387-93. PubMed ID: 4473562
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of 3-methylcholanthrene on the endocrine system and metabolism of the rat and its influence to retard growth of mammary tumors hitherto refractory.
    HUGGINS C; POLLICE L
    J Exp Med; 1958 Jan; 107(1):13-32. PubMed ID: 13481252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Some biochemical characteristics of rodent and human mammary carcinomas.
    Hilf R; Goldenberg H; Bell C; Michel I; Orlando RA; Archer FL
    Enzymol Biol Clin (Basel); 1970; 11(1):162-76. PubMed ID: 4313121
    [No Abstract]   [Full Text] [Related]  

  • 54. Levels of 3-methylcholanthrene and 7, 12-dimethylbenz[alpha]anthracene in rat mammary fat pads after intragastric administration, and relationships to carcinogenic response.
    Wieder R; Thatcher D; Shimkin MB
    J Natl Cancer Inst; 1967 Jun; 38(6):959-67. PubMed ID: 6026109
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of a norethynodrel-mestranol combination (enovid) on development and growth of carcinogen-induced mammary tumors in female rats.
    Welsch CW; Meites J
    Cancer; 1969 Mar; 23(3):601-7. PubMed ID: 5766502
    [No Abstract]   [Full Text] [Related]  

  • 56. Relationship of hyperplasia to cancer in 3-methylcholanthrene-induced mammary tumorogenesis.
    Fisher ER; Shoemaker RH; Sabnis A
    Lab Invest; 1975 Jul; 33(1):33-42. PubMed ID: 1142740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Morphology, growth characteristics and oestrogen-binding capacity of DMBA-induced mammary tumours from ovariectomized rats.
    Boylan ES; Fowler EH; Wittliff JL
    Br J Cancer; 1977 May; 35(5):602-9. PubMed ID: 405032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of reserpine on development of 7,12-dimethylbenzanthracene induced mammary tumors in female rats.
    Welsch CW; Meites J
    Experientia; 1970 Oct; 26(10):1133-4. PubMed ID: 5483769
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of triiodothyronine and reserpine on induction and growth of mammary tumors in rats by 3-methylcholanthrene.
    Gerard SS; Gardner B; Patti J; Husain V; Shouten J; Alfonso AE
    J Surg Oncol; 1980; 14(3):213-8. PubMed ID: 7392644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The production of mammary tumours in rats feeding with 3-methylcholanthrene.
    DANIEL PM; PRICHARD MM
    Br J Cancer; 1961 Dec; 15(4):828-32. PubMed ID: 13883390
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.